However, sex biased response to PD-L1 blockade was observed by Lin et al. In this study, they showed in a preclinical model, in which mice were injected with B16F10 melanoma cells that anti-PD-L1 treatment significantly reduced tumor growth in female compared to male mice. The gene discussed is CD274; the disease is melanoma.